FDA reviewers have identified high rates of ocular toxicity as GSK looks to place its blood cancer drug back on the market.

With the aim of being the largest life science sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.

The White House’s decision to safeguard $400m in President’s Emergency Plan for AIDS Relief (PEPFAR) funding to support the global human immunodeficiency virus (HIV) emergency provides “hope” to ...

Navamedic has completed its previously announced acquisition of dne pharma's business for up to Nkr225m ($22m).

As supply chain disruption persists in pharma, global logistics providers with the expertise to overcome any challenge are essential.